Cargando…
In Vitro and In Vivo Validation of EP2-Receptor Agonism to Selectively Achieve Inhibition of Mast Cell Activity
PURPOSE: Agonism of the prostaglandin E2 receptor, E-prostanoid receptor 2 (EP2), may represent an alternative protective mechanism in mast cell (MC)-mediated diseases. Previous studies have suggested that activation of the MC EP2 receptor prevents pathological changes in the murine models of allerg...
Autores principales: | Plaza, Judith, Torres, Rosa, Urbano, Adrián, Picado, César, de Mora, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225001/ https://www.ncbi.nlm.nih.gov/pubmed/32400135 http://dx.doi.org/10.4168/aair.2020.12.4.712 |
Ejemplares similares
-
Prostaglandin E(2) Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP(2) and EP(4)
por: Torres-Atencio, Ivonne, et al.
Publicado: (2014) -
Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2)
por: Mullol, Joaquim, et al.
Publicado: (2013) -
Molecular mechanism of agonism and inverse agonism in ghrelin receptor
por: Qin, Jiao, et al.
Publicado: (2022) -
Biased agonism
por: Kenakin, Terry
Publicado: (2009) -
Agonizing Hedgehog
por: Weitzman, Jonathan B
Publicado: (2002)